1. MARKETS
  2. SECTOR : HEALTHCARE & MEDICAL EQUIPMENT SUPPLIERS
  3. INDUSTRY : MEDICAL SPECIALTIES
  4. NOVOCURE LTD
NovoCure Ltd
XNAS: NVCR
Momentum Trap
Download real time
16.93 0.31 (1.87%)
72.40% Gain from 52W Low
3.1M
XNAS Volume
High vol.+gain this week

XNAS 04 May, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert


Insider Trading disclosures for NovoCure Ltd

The latest disclosure was made by W. Anthony Vernon in NovoCure Ltd where a trade of 21,500 Stock Option (Right to Buy) done was reported to US exchanges on April 28, 2026.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
W. Anthony Vernon Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Apr 2026 21,500 0 - - Stock Option (Right to Buy)
W. Anthony Vernon Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.39 per share. 28 Apr 2026 21,500 200,602 (0%) 0% 11.4 244,885 Ordinary Shares
Ashley Cordova Former Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.30 per share. 04 Mar 2026 17,638 422,570 (0%) 0% 13.3 234,585 Ordinary Shares
Nicholas Leupin Former Chief Medical Officer Sale of securities on an exchange or to another person at price $ 13.31 per share. 04 Mar 2026 1,100 102,979 (0%) 0% 13.3 14,636 Ordinary Shares
William F. Doyle Director, Executive Chairman Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2026 200,284 400,284 (0%) 0% 0 Ordinary Shares
William F. Doyle Director, Executive Chairman Sale of securities on an exchange or to another person at price $ 13.43 per share. 03 Mar 2026 21,330 328,397 (0%) 0% 13.4 286,436 Ordinary Shares
William F. Doyle Director, Executive Chairman Sale of securities on an exchange or to another person at price $ 12.79 per share. 03 Mar 2026 50,557 349,727 (0%) 0% 12.8 646,447 Ordinary Shares
William F. Doyle Director, Executive Chairman Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2026 200,000 200,000 (0%) 0% 0 Ordinary Shares
William F. Doyle Director, Executive Chairman Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2026 30,072 288,517 - - Stock Option (Right to Buy)
William F. Doyle Director, Executive Chairman Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2026 258,445 258,445 - - Stock Option (Right to Buy)
Uri Weinberg Chf Medical and Innovation Ofr Sale of securities on an exchange or to another person at price $ 13.31 per share. 03 Mar 2026 6,412 267,190 (0%) 0% 13.3 85,314 Ordinary Shares
Uri Weinberg Chf Medical and Innovation Ofr Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2026 50,125 273,602 (0%) 0% 0 Ordinary Shares
Uri Weinberg Chf Medical and Innovation Ofr Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2026 73,340 73,340 - - Stock Option (Right to Buy)
Francis Leonard Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2026 216,388 216,388 - - Stock Option (Right to Buy)
Francis Leonard Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2026 150,000 499,400 (0%) 0% 0 Ordinary Shares
Francis Leonard Chief Executive Officer Sale of securities on an exchange or to another person at price $ 13.31 per share. 03 Mar 2026 5,607 493,793 (0%) 0% 13.3 74,603 Ordinary Shares
Barak Ben Arye General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2026 50,125 242,453 (0%) 0% 0 Ordinary Shares
Barak Ben Arye General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2026 73,340 73,340 - - Stock Option (Right to Buy)
Michal Nath Puri Chief Human Resources Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2026 58,672 58,672 - - Stock Option (Right to Buy)
Michal Nath Puri Chief Human Resources Officer Sale of securities on an exchange or to another person at price $ 13.31 per share. 03 Mar 2026 1,100 201,322 (0%) 0% 13.3 14,636 Ordinary Shares
Michal Nath Puri Chief Human Resources Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2026 40,100 202,422 (0%) 0% 0 Ordinary Shares
Mukund Paravasthu Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2026 58,488 66,006 - - Stock Option (Right to Buy)
Mukund Paravasthu Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2026 45,112 121,455 (0%) 0% 0 Ordinary Shares
Mukund Paravasthu Chief Operating Officer Sale of securities on an exchange or to another person at price $ 13.31 per share. 03 Mar 2026 5,377 116,078 (0%) 0% 13.3 71,543 Ordinary Shares
Mukund Paravasthu Chief Operating Officer Sale of securities on an exchange or to another person at price $ 13.77 per share. 03 Mar 2026 43,246 72,832 (0%) 0% 13.8 595,670 Ordinary Shares
Mukund Paravasthu Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2026 7,518 7,518 - - Stock Option (Right to Buy)
Christoph Brackmann Chief Financial Officer Sale of securities on an exchange or to another person at price $ 13.31 per share. 03 Mar 2026 6,412 182,842 (0%) 0% 13.3 85,314 Ordinary Shares
Christoph Brackmann Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2026 55,137 189,254 (0%) 0% 0 Ordinary Shares
Christoph Brackmann Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2026 80,674 80,674 - - Stock Option (Right to Buy)
Barak Ben Arye General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2026 17,755 192,328 (0%) 0% 0 Ordinary Shares
Uri Weinberg Chf Medical and Innovation Ofr Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Feb 2026 12,992 226,749 (0%) 0% 0 Ordinary Shares
Uri Weinberg Chf Medical and Innovation Ofr Sale of securities on an exchange or to another person at price $ 13.84 per share. 27 Feb 2026 7,461 213,757 (0%) 0% 13.8 103,257 Ordinary Shares
Uri Weinberg Chf Medical and Innovation Ofr Sale of securities on an exchange or to another person at price $ 13.33 per share. 27 Feb 2026 3,272 223,477 (0%) 0% 13.3 43,607 Ordinary Shares
Ashley Cordova Former Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.75 per share. 27 Feb 2026 11,541 426,028 (0%) 0% 13.8 158,689 Ordinary Shares
Ashley Cordova Former Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.67 per share. 27 Feb 2026 7,228 440,208 (0%) 0% 13.7 98,807 Ordinary Shares
Ashley Cordova Former Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.67 per share. 27 Feb 2026 2,410 447,436 (0%) 0% 13.7 32,945 Ordinary Shares
Ashley Cordova Former Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Feb 2026 23,818 449,846 (0%) 0% 0 Ordinary Shares
Francis Leonard Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Feb 2026 18,621 356,632 (0%) 0% 0 Ordinary Shares
Francis Leonard Chief Executive Officer Sale of securities on an exchange or to another person at price $ 13.66 per share. 27 Feb 2026 9,734 338,011 (0%) 0% 13.7 133,003 Ordinary Shares
Francis Leonard Chief Executive Officer Sale of securities on an exchange or to another person at price $ 13.49 per share. 27 Feb 2026 7,232 349,400 (0%) 0% 13.5 97,581 Ordinary Shares
Michal Nath Puri Chief Human Resources Officer Sale of securities on an exchange or to another person at price $ 13.66 per share. 27 Feb 2026 1,441 162,322 (0%) 0% 13.7 19,690 Ordinary Shares
Nicholas Leupin Former Chief Medical Officer Sale of securities on an exchange or to another person at price $ 13.66 per share. 27 Feb 2026 1,029 104,079 (0%) 0% 13.7 14,060 Ordinary Shares
Mukund Paravasthu Chief Operating Officer Sale of securities on an exchange or to another person at price $ 13.49 per share. 27 Feb 2026 408 76,343 (0%) 0% 13.5 5,505 Ordinary Shares
Mukund Paravasthu Chief Operating Officer Sale of securities on an exchange or to another person at price $ 13.66 per share. 27 Feb 2026 1,555 76,751 (0%) 0% 13.7 21,247 Ordinary Shares
Mukund Paravasthu Chief Operating Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.35 per share. 11 Jan 2026 2,133 78,306 (0%) 0% 14.4 30,609 Ordinary Shares
Asaf Danziger Director Grant, award, or other acquisition of securities at price $ 11.00 per share. 31 Dec 2025 1 416,474 (0%) 0% 11 11 Ordinary Shares
Barak Ben Arye General Counsel Grant, award, or other acquisition of securities at price $ 10.99 per share. 31 Dec 2025 108 174,573 (0%) 0% 11.0 1,187 Ordinary Shares
Michal Nath Puri Chief Human Resources Officer Grant, award, or other acquisition of securities at price $ 11.00 per share. 31 Dec 2025 1 163,763 (0%) 0% 11 11 Ordinary Shares
Christoph Brackmann Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.23 per share. 04 Nov 2025 7,033 134,117 (0%) 0% 12.2 86,014 Ordinary Shares
Francis Leonard EVP, Pres., Novocure Oncology Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.81 per share. 01 Nov 2025 966 347,745 (0%) 0% 12.8 12,374 Ordinary Shares
Mukund Paravasthu Chief Operating Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.23 per share. 01 Nov 2025 2,949 80,439 (0%) 0% 12.2 36,066 Ordinary Shares
Mukund Paravasthu Chief Operating Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.81 per share. 01 Nov 2025 168 83,388 (0%) 0% 12.8 2,152 Ordinary Shares
Michal Nath Puri Chief Human Resources Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.82 per share. 31 Oct 2025 752 163,762 (0%) 0% 12.8 9,641 Ordinary Shares
Ashley Cordova Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 12.22 per share. 05 Sep 2025 81,550 437,569 (0%) 0% 12.2 996,859 Ordinary Shares
Christoph Brackmann Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 11.50 per share. 29 Jul 2025 5,000 141,150 (0%) 0% 11.5 57,500 Ordinary Shares
Christoph Brackmann Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 11.60 per share. 29 Jul 2025 5,000 136,150 (0%) 0% 11.6 58,000 Ordinary Shares
Christoph Brackmann Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 11.63 per share. 29 Jul 2025 10,000 131,150 (0%) 0% 11.6 116,300 Ordinary Shares
Asaf Danziger Director Grant, award, or other acquisition of securities at price $ 15.13 per share. 30 Jun 2025 833 416,473 (0%) 0% 15.1 12,603 Ordinary Shares
Ashley Cordova Chief Executive Officer Grant, award, or other acquisition of securities at price $ 15.13 per share. 30 Jun 2025 833 356,019 (0%) 0% 15.1 12,603 Ordinary Shares
Francis Leonard EVP, Pres., Novocure Oncology Grant, award, or other acquisition of securities at price $ 15.13 per share. 30 Jun 2025 833 348,711 (0%) 0% 15.1 12,603 Ordinary Shares
Barak Ben Arye General Counsel Grant, award, or other acquisition of securities at price $ 15.13 per share. 30 Jun 2025 769 174,465 (0%) 0% 15.1 11,635 Ordinary Shares
Michal Nath Puri Chief Human Resources Officer Grant, award, or other acquisition of securities at price $ 15.13 per share. 30 Jun 2025 833 164,514 (0%) 0% 15.1 12,603 Ordinary Shares
Gabriel Leung Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2025 11,215 92,444 (0%) 0% 0 Ordinary Shares
Gabriel Leung Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2025 16,697 16,697 - - Stock Option (Right to Buy)
Timothy John Scannell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2025 11,215 17,233 (0%) 0% 0 Ordinary Shares
Timothy John Scannell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2025 16,697 16,697 - - Stock Option (Right to Buy)
David T. Hung Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2025 11,215 23,410 (0%) 0% 0 Ordinary Shares
David T. Hung Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2025 16,697 16,697 - - Stock Option (Right to Buy)
Jeryl L. Hilleman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2025 16,697 16,697 - - Stock Option (Right to Buy)
Jeryl L. Hilleman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2025 11,215 16,806 (0%) 0% 0 Ordinary Shares
W. Anthony Vernon Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2025 11,215 179,102 (0%) 0% 0 Ordinary Shares
W. Anthony Vernon Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2025 16,697 16,697 - - Stock Option (Right to Buy)
Martin J. Madden Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2025 33,393 33,393 - - Stock Option (Right to Buy)
Francis Leonard EVP, Pres., Novocure Oncology Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2025 179,426 347,878 (0%) 0% 0 Ordinary Shares
Kristin Stafford Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2025 11,215 14,269 (0%) 0% 0 Ordinary Shares
Kristin Stafford Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2025 16,697 16,697 - - Stock Option (Right to Buy)
Allyson J. Ocean Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2025 16,697 16,697 - - Stock Option (Right to Buy)
Allyson J. Ocean Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2025 11,215 14,269 (0%) 0% 0 Ordinary Shares
Gabriel Leung Director Sale of securities on an exchange or to another person at price $ 17.31 per share. 03 Jun 2025 999 81,229 (0%) 0% 17.3 17,297 Ordinary Shares
Timothy John Scannell Director Sale of securities on an exchange or to another person at price $ 17.32 per share. 03 Jun 2025 999 6,018 (0%) 0% 17.3 17,299 Ordinary Shares
David T. Hung Director Sale of securities on an exchange or to another person at price $ 17.30 per share. 03 Jun 2025 999 12,195 (0%) 0% 17.3 17,280 Ordinary Shares
Jeryl L. Hilleman Director Sale of securities on an exchange or to another person at price $ 17.26 per share. 03 Jun 2025 999 5,591 (0%) 0% 17.3 17,247 Ordinary Shares
W. Anthony Vernon Director Sale of securities on an exchange or to another person at price $ 17.35 per share. 03 Jun 2025 999 167,887 (0%) 0% 17.3 17,329 Ordinary Shares
Martin J. Madden Director Sale of securities on an exchange or to another person at price $ 17.19 per share. 03 Jun 2025 999 18,674 (0%) 0% 17.2 17,176 Ordinary Shares
Kristin Stafford Director Sale of securities on an exchange or to another person at price $ 17.28 per share. 03 Jun 2025 999 3,054 (0%) 0% 17.3 17,259 Ordinary Shares
Allyson J. Ocean Director Sale of securities on an exchange or to another person at price $ 17.29 per share. 03 Jun 2025 999 3,054 (0%) 0% 17.3 17,269 Ordinary Shares
Francis Leonard EVP, Pres., Novocure Oncology Sale of securities on an exchange or to another person at price $ 17.22 per share. 02 Jun 2025 21,717 176,931 (0%) 0% 17.2 373,958 Ordinary Shares
Francis Leonard EVP, Pres., Novocure Oncology Sale of securities on an exchange or to another person at price $ 19.01 per share. 02 Jun 2025 1,879 168,452 (0%) 0% 19.0 35,722 Ordinary Shares
Francis Leonard EVP, Pres., Novocure Oncology Sale of securities on an exchange or to another person at price $ 17.99 per share. 02 Jun 2025 6,600 170,331 (0%) 0% 18.0 118,733 Ordinary Shares
Mukund Paravasthu Chief Operating Officer Sale of securities on an exchange or to another person at price $ 17.91 per share. 03 May 2025 592 83,556 (0%) 0% 17.9 10,604 Ordinary Shares
Uri Weinberg Chief Innovation Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Mar 2025 81,499 81,499 - - Stock Options (Right to buy)
Uri Weinberg Chief Innovation Officer Grant, award, or other acquisition of securities at price $ 18.19 per share. 04 Mar 2025 54,975 221,218 (0%) 0% 18.2 999,995 Ordinary Shares
Ashley Cordova Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Mar 2025 224,123 224,123 - - Stock Options (Right to buy)
Ashley Cordova Chief Executive Officer Grant, award, or other acquisition of securities at price $ 18.19 per share. 04 Mar 2025 151,181 355,186 (0%) 0% 18.2 2,749,982 Ordinary Shares
Francis Leonard EVP, Pres., Novocure Oncology Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Mar 2025 81,499 81,499 - - Stock Options (Right to buy)
Francis Leonard EVP, Pres., Novocure Oncology Grant, award, or other acquisition of securities at price $ 18.19 per share. 04 Mar 2025 54,975 198,648 (0%) 0% 18.2 999,995 Ordinary Shares
Barak Ben Arye General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Mar 2025 81,499 81,499 - - Stock Options (Right to buy)
Barak Ben Arye General Counsel Grant, award, or other acquisition of securities at price $ 18.19 per share. 04 Mar 2025 54,975 173,696 (0%) 0% 18.2 999,995 Ordinary Shares
Michal Nath Puri Chief Human Resources Officer Grant, award, or other acquisition of securities at price $ 18.19 per share. 04 Mar 2025 54,975 163,681 (0%) 0% 18.2 999,995 Ordinary Shares
Michal Nath Puri Chief Human Resources Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Mar 2025 81,499 81,499 - - Stock Options (Right to buy)
Nicholas Leupin Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Mar 2025 81,499 81,499 - - Stock Options (Right to buy)
Nicholas Leupin Chief Medical Officer Grant, award, or other acquisition of securities at price $ 18.19 per share. 04 Mar 2025 54,975 105,108 (0%) 0% 18.2 999,995 Ordinary Shares
Mukund Paravasthu Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Mar 2025 81,499 81,499 - - Stock Options (Right to buy)
Mukund Paravasthu Chief Operating Officer Grant, award, or other acquisition of securities at price $ 18.19 per share. 04 Mar 2025 54,975 84,148 (0%) 0% 18.2 999,995 Ordinary Shares
Christoph Brackmann Chief Financial Officer Grant, award, or other acquisition of securities at price $ 18.19 per share. 04 Mar 2025 54,975 121,150 (0%) 0% 18.2 999,995 Ordinary Shares
Christoph Brackmann Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Mar 2025 81,499 81,499 - - Stock Options (Right to buy)
Uri Weinberg Chief Innovation Officer Sale of securities on an exchange or to another person at price $ 18.31 per share. 03 Mar 2025 311 166,511 (0%) 0% 18.3 5,695 Ordinary Shares
Uri Weinberg Chief Innovation Officer Sale of securities on an exchange or to another person at price $ 18.78 per share. 03 Mar 2025 4,326 166,822 (0%) 0% 18.8 81,254 Ordinary Shares
Uri Weinberg Chief Innovation Officer Sale of securities on an exchange or to another person at price $ 18.92 per share. 03 Mar 2025 268 166,243 (0%) 0% 18.9 5,071 Ordinary Shares
Ashley Cordova Chief Executive Officer Sale of securities on an exchange or to another person at price $ 18.54 per share. 03 Mar 2025 2,053 204,005 (0%) 0% 18.5 38,055 Ordinary Shares
Francis Leonard EVP, Pres., Novocure Oncology Sale of securities on an exchange or to another person at price $ 18.54 per share. 03 Mar 2025 2,527 143,673 (0%) 0% 18.5 46,841 Ordinary Shares
Mukund Paravasthu Chief Operating Officer Sale of securities on an exchange or to another person at price $ 18.54 per share. 03 Mar 2025 250 29,173 (0%) 0% 18.5 4,634 Ordinary Shares
Ashley Cordova Chief Executive Officer Sale of securities on an exchange or to another person at price $ 20.55 per share. 27 Feb 2025 1,808 208,399 (0%) 0% 20.5 37,153 Ordinary Shares
Ashley Cordova Chief Executive Officer Sale of securities on an exchange or to another person at price $ 18.28 per share. 27 Feb 2025 2,341 206,058 (0%) 0% 18.3 42,804 Ordinary Shares
Ashley Cordova Chief Executive Officer Sale of securities on an exchange or to another person at price $ 19.92 per share. 27 Feb 2025 9,345 210,207 (0%) 0% 19.9 186,170 Ordinary Shares
Francis Leonard EVP, Pres., Novocure Oncology Sale of securities on an exchange or to another person at price $ 20.55 per share. 27 Feb 2025 1,989 148,970 (0%) 0% 20.5 40,872 Ordinary Shares
Francis Leonard EVP, Pres., Novocure Oncology Sale of securities on an exchange or to another person at price $ 18.28 per share. 27 Feb 2025 2,770 146,200 (0%) 0% 18.3 50,648 Ordinary Shares
Francis Leonard EVP, Pres., Novocure Oncology Sale of securities on an exchange or to another person at price $ 19.92 per share. 27 Feb 2025 10,277 150,959 (0%) 0% 19.9 204,737 Ordinary Shares
Michal Nath Puri Chief Human Resources Officer Sale of securities on an exchange or to another person at price $ 19.92 per share. 27 Feb 2025 1,162 108,931 (0%) 0% 19.9 23,149 Ordinary Shares
Michal Nath Puri Chief Human Resources Officer Sale of securities on an exchange or to another person at price $ 20.55 per share. 27 Feb 2025 225 108,706 (0%) 0% 20.6 4,624 Ordinary Shares
Nicholas Leupin Chief Medical Officer Sale of securities on an exchange or to another person at price $ 20.55 per share. 27 Feb 2025 161 50,133 (0%) 0% 20.5 3,308 Ordinary Shares
Nicholas Leupin Chief Medical Officer Sale of securities on an exchange or to another person at price $ 19.92 per share. 27 Feb 2025 830 50,294 (0%) 0% 19.9 16,535 Ordinary Shares
Mukund Paravasthu Chief Operating Officer Sale of securities on an exchange or to another person at price $ 20.55 per share. 27 Feb 2025 267 29,791 (0%) 0% 20.6 5,487 Ordinary Shares
Mukund Paravasthu Chief Operating Officer Sale of securities on an exchange or to another person at price $ 19.92 per share. 27 Feb 2025 1,379 30,058 (0%) 0% 19.9 27,472 Ordinary Shares
Mukund Paravasthu Chief Operating Officer Sale of securities on an exchange or to another person at price $ 18.29 per share. 27 Feb 2025 368 29,423 (0%) 0% 18.3 6,729 Ordinary Shares
Mukund Paravasthu Chief Operating Officer Sale of securities on an exchange or to another person at price $ 26.81 per share. 11 Jan 2025 2,160 31,437 (0%) 0% 26.8 57,906 Ordinary Shares
Asaf Danziger Director Grant, award, or other acquisition of securities at price $ 14.75 per share. 01 Jan 2025 412 15,640 (0%) 0% 14.7 6,076 Ordinary Shares
Asaf Danziger Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2025 400,000 415,640 (0%) 0% 0 Ordinary Shares
Ashley Cordova Chief Executive Officer 31 Dec 2024 373 219,552 (0%) 0% 14.7 5,501 Ordinary Shares
Barak Ben Arye General Counsel Grant, award, or other acquisition of securities at price $ 14.75 per share. 31 Dec 2024 669 118,721 (0%) 0% 14.7 9,866 Ordinary Shares
Mukund Paravasthu Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Nov 2024 30,138 33,597 (0%) 0% 0 Ordinary Shares
Mukund Paravasthu Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Nov 2024 45,620 45,620 - - Stock Option (Right to Buy)
Mukund Paravasthu Chief Operating Officer Sale of securities on an exchange or to another person at price $ 16.68 per share. 02 Nov 2024 44 3,459 (0%) 0% 16.7 734 Ordinary Shares
Francis Leonard EVP, Pres., Novocure Oncology Sale of securities on an exchange or to another person at price $ 15.94 per share. 01 Nov 2024 598 161,236 (0%) 0% 15.9 9,531 Ordinary Shares
Mukund Paravasthu Chief Operating Officer Sale of securities on an exchange or to another person at price $ 15.88 per share. 01 Nov 2024 160 3,503 (0%) 0% 15.9 2,540 Ordinary Shares
Michal Nath Puri Chief Human Resources Officer Sale of securities on an exchange or to another person at price $ 15.79 per share. 31 Oct 2024 810 110,093 (0%) 0% 15.8 12,792 Ordinary Shares
Ashley Cordova Chief Financial Officer 02 Aug 2024 688 219,179 (0%) 0% 20.1 13,857 Ordinary Shares
Wilhelmus C. M. Groenhuysen Chief Operating Officer Grant, award, or other acquisition of securities at price $ 12.24 per share. 28 Jun 2024 1,055 252,290 (0%) 0% 12.2 12,913 Ordinary Shares
Asaf Danziger Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 12.24 per share. 28 Jun 2024 1,239 15,228 (0%) 0% 12.2 15,165 Ordinary Shares
Ashley Cordova Chief Financial Officer 28 Jun 2024 1,286 220,465 (0%) 0% 12.2 15,741 Ordinary Shares
Francis Leonard EVP, Pres., Novocure Oncology Grant, award, or other acquisition of securities at price $ 12.24 per share. 28 Jun 2024 1,736 161,834 (0%) 0% 12.2 21,249 Ordinary Shares
Barak Ben Arye General Counsel Grant, award, or other acquisition of securities at price $ 12.24 per share. 28 Jun 2024 930 118,052 (0%) 0% 12.2 11,383 Ordinary Shares
Michal Nath Puri Chief Human Resources Officer Grant, award, or other acquisition of securities at price $ 12.24 per share. 28 Jun 2024 1,736 110,903 (0%) 0% 12.2 21,249 Ordinary Shares
Wilhelmus C. M. Groenhuysen Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Jun 2024 124,373 95,000 - - Stock Options (Right to buy)
Wilhelmus C. M. Groenhuysen Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.82 per share. 05 Jun 2024 124,373 124,373 (0%) 0% 22.8 2,838,192 Ordinary Shares
David T. Hung Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2024 6,229 6,229 - - Stock Option (Right to Buy)
David T. Hung Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2024 4,053 13,194 - 0 Restricted Stock Units
Jeryl L. Hilleman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2024 6,229 6,229 - - Stock Option (Right to Buy)
Jeryl L. Hilleman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2024 4,053 6,590 - 0 Restricted Stock Units
Martin J. Madden Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2024 4,053 19,673 (0%) 0% 0 Ordinary Shares
Martin J. Madden Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2024 6,229 6,229 - - Stock Option (Right to Buy)
Allyson J. Ocean Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2024 4,053 4,053 - 0 Restricted Stock Units
Allyson J. Ocean Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2024 6,229 6,229 - - Stock Options (Right to buy)
Gabriel Leung Director Sale of securities on an exchange or to another person at price $ 23.88 per share. 04 Jun 2024 964 78,175 (0%) 0% 23.9 23,025 Ordinary Shares
Gabriel Leung Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2024 6,229 6,229 - - Stock Option (Right to Buy)
Gabriel Leung Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2024 4,053 83,192 - 0 Restricted Stock Units
Timothy John Scannell Director Sale of securities on an exchange or to another person at price $ 23.89 per share. 04 Jun 2024 964 2,964 (0%) 0% 23.9 23,027 Ordinary Shares
Timothy John Scannell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2024 6,229 6,229 - - Stock Option (Right to Buy)
Timothy John Scannell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2024 4,053 7,981 - 0 Restricted Stock Units
W. Anthony Vernon Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2024 6,229 6,229 - - Stock Option (Right to Buy)
W. Anthony Vernon Director Sale of securities on an exchange or to another person at price $ 23.89 per share. 04 Jun 2024 964 164,833 (0%) 0% 23.9 23,033 Ordinary Shares
W. Anthony Vernon Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2024 4,053 169,850 - 0 Restricted Stock Units
Wilhelmus C. M. Groenhuysen Chief Operating Officer Sale of securities on an exchange or to another person at price $ 16.01 per share. 01 Mar 2024 1,217 251,235 (0%) 0% 16.0 19,484 Ordinary Shares
Wilhelmus C. M. Groenhuysen Chief Operating Officer Sale of securities on an exchange or to another person at price $ 16.03 per share. 01 Mar 2024 2,107 252,452 (0%) 0% 16.0 33,769 Ordinary Shares
Frank Leonard EVP, Pres., Novocure Oncology Sale of securities on an exchange or to another person at price $ 16.03 per share. 01 Mar 2024 1,679 160,938 (0%) 0% 16.0 26,909 Ordinary Shares
Frank Leonard EVP, Pres., Novocure Oncology Sale of securities on an exchange or to another person at price $ 16.01 per share. 01 Mar 2024 840 160,098 (0%) 0% 16.0 13,448 Ordinary Shares
Wilhelmus C. M. Groenhuysen Chief Operating Officer Sale of securities on an exchange or to another person at price $ 16.14 per share. 27 Feb 2024 2,303 254,559 (0%) 0% 16.1 37,177 Ordinary Shares
Leupin Nicholas Chief Medical Officer Grant, award, or other acquisition of securities at price $ 16.30 per share. 27 Feb 2024 51,124 51,124 (0%) 0% 16.3 833,321 Ordinary Shares
Uri Weinberg Chief Innovation Officer Grant, award, or other acquisition of securities at price $ 16.30 per share. 27 Feb 2024 81,799 171,148 (0%) 0% 16.3 1,333,324 Ordinary Shares
Barak Arye Ben General Counsel Grant, award, or other acquisition of securities at price $ 16.30 per share. 27 Feb 2024 81,799 117,122 (0%) 0% 16.3 1,333,324 Ordinary Shares
Giladi Moshe Chief Science Officer 27 Feb 2024 51,124 69,771 (0%) 0% 16.3 833,321 Ordinary Shares
Ben Arye Barak General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Feb 2024 125,078 125,078 - - Stock Options (Right to buy)
Nicholas Leupin Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Feb 2024 78,174 78,174 - - Stock Options (Right to buy)
Michal Nath Puri Chief Human Resources Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Feb 2024 109,443 109,443 - - Stock Options (Right to buy)
Ashley Cordova Chief Financial Officer 27 Feb 2024 156,348 156,348 - - Stock Options (Right to buy)
Groenhuysen C. M. Wilhelmus Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Feb 2024 71,920 71,920 - - Stock Options (Right to buy)
C. M. Wilhelmus Groenhuysen Chief Operating Officer Grant, award, or other acquisition of securities at price $ 16.30 per share. 27 Feb 2024 47,034 256,862 (0%) 0% 16.3 766,654 Ordinary Shares
Arye Barak Ben General Counsel Grant, award, or other acquisition of securities at price $ 12.69 per share. 27 Feb 2024 128 35,323 (0%) 0% 12.7 1,624 Ordinary Shares
Ashley Cordova Chief Financial Officer 27 Feb 2024 102,249 219,867 (0%) 0% 16.3 1,666,659 Ordinary Shares
Frank Leonard EVP, Pres., Novocure Oncology Grant, award, or other acquisition of securities at price $ 16.30 per share. 27 Feb 2024 102,249 164,695 (0%) 0% 16.3 1,666,659 Ordinary Shares
Nath Michal Puri Chief Human Resources Officer Grant, award, or other acquisition of securities at price $ 16.30 per share. 27 Feb 2024 71,574 109,167 (0%) 0% 16.3 1,166,656 Ordinary Shares
Weinberg Uri Chief Innovation Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Feb 2024 125,078 125,078 - - Stock Options (Right to buy)
Wilhelmus Groenhuysen C. M. Chief Operating Officer Grant, award, or other acquisition of securities at price $ 12.67 per share. 27 Feb 2024 3 209,828 (0%) 0% 12.7 38 Ordinary Shares
Giladi Moshe Chief Science Officer 27 Feb 2024 78,174 78,174 - - Stock Options (Right to buy)
Frank Leonard EVP, Pres., Novocure Oncology Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Feb 2024 156,348 156,348 - - Stock Options (Right to buy)
Leonard Frank EVP, Pres., Novocure Oncology Sale of securities on an exchange or to another person at price $ 16.14 per share. 27 Feb 2024 2,078 162,617 (0%) 0% 16.1 33,545 Ordinary Shares
Pritesh Shah Chief Growth Officer Sale of securities on an exchange or to another person at price $ 12.65 per share. 07 Nov 2023 382 124,511 (0%) 0% 12.6 4,832 Ordinary Shares
Ashley Cordova Chief Financial Officer 31 Oct 2023 7,561 107,211 (0%) 0% 11.5 86,649 Ordinary Shares
Ashley Cordova Chief Financial Officer 31 Oct 2023 2,480 109,691 (0%) 0% 11.4 28,371 Ordinary Shares
Ashley Cordova Chief Financial Officer 31 Oct 2023 7,752 117,443 (0%) 0% 7.2 55,427 Ordinary Shares
Ashley Cordova Chief Financial Officer 31 Oct 2023 7,561 175 - - Stock Option (Right to Buy)
Ashley Cordova Chief Financial Officer 31 Oct 2023 175 117,618 (0%) 0% 11.5 2,006 Ordinary Shares
Ashley Cordova Chief Financial Officer 31 Oct 2023 175 0 - - Stock Option (Right to Buy)
Ashley Cordova Chief Financial Officer 31 Oct 2023 7,752 0 - - Stock Option (Right to Buy)
Ashley Cordova Chief Financial Officer 31 Oct 2023 2,480 0 - - Stock Option (Right to Buy)
Michal Nath Puri Chief Human Resources Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Oct 2023 57,604 57,604 - - Stock Option (Right to Buy)
Michal Nath Puri Chief Human Resources Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Oct 2023 37,593 37,593 (0%) 0% 0 Ordinary Shares
Pritesh Shah Chief Growth Officer Sale of securities on an exchange or to another person at price $ 21.82 per share. 01 Sep 2023 273 124,893 (0%) 0% 21.8 5,956 Ordinary Shares
Wilhelmus C. M. Groenhuysen Chief Operating Officer Sale of securities on an exchange or to another person at price $ 21.82 per share. 01 Sep 2023 294 209,825 (0%) 0% 21.8 6,414 Ordinary Shares
Ashley Cordova Chief Financial Officer 01 Sep 2023 883 99,650 (0%) 0% 21.8 19,265 Ordinary Shares
Ashley Cordova Chief Financial Officer 02 Aug 2023 1,144 100,533 (0%) 0% 30.3 34,607 Ordinary Shares
Wilhelmus C. M. Groenhuysen Chief Operating Officer Grant, award, or other acquisition of securities at price $ 35.28 per share. 30 Jun 2023 366 210,119 (0%) 0% 35.3 12,912 Ordinary Shares
Asaf Danziger Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 35.28 per share. 30 Jun 2023 367 13,989 (0%) 0% 35.3 12,948 Ordinary Shares
Pritesh Shah Chief Growth Officer Grant, award, or other acquisition of securities at price $ 35.28 per share. 30 Jun 2023 367 125,166 (0%) 0% 35.3 12,948 Ordinary Shares
Uri Weinberg Chief Innovation Officer Grant, award, or other acquisition of securities at price $ 35.28 per share. 30 Jun 2023 305 89,349 (0%) 0% 35.3 10,760 Ordinary Shares
Ashley Cordova Chief Financial Officer 30 Jun 2023 367 101,677 (0%) 0% 35.3 12,948 Ordinary Shares
William Patrick Burke Chief Human Resources Officer Grant, award, or other acquisition of securities at price $ 35.28 per share. 30 Jun 2023 357 66,447 (0%) 0% 35.3 12,595 Ordinary Shares
Barak Ben Arye General Counsel Grant, award, or other acquisition of securities at price $ 35.28 per share. 30 Jun 2023 288 35,195 (0%) 0% 35.3 10,161 Ordinary Shares
Gabriel Leung Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2023 3,853 79,139 - 0 Restricted Stock Units
Gabriel Leung Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2023 6,277 6,277 - - Stock Option (Right to Buy)
Timothy John Scannell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2023 6,277 6,277 - - Stock Option (Right to Buy)
Timothy John Scannell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2023 3,853 3,928 - 0 Restricted Stock Units
David T. Hung Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2023 12,554 12,554 - - Stock Option (Right to Buy)
Jeryl L. Hilleman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2023 12,554 12,554 - - Stock Option (Right to Buy)
W. Anthony Vernon Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2023 6,277 6,277 - - Stock Option (Right to Buy)
W. Anthony Vernon Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2023 3,853 165,797 - 0 Restricted Stock Units
Martin J. Madden Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2023 12,554 12,554 - - Stock Option (Right to Buy)
Kristin Stafford Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2023 6,229 6,229 - - Stock Option (Right to Buy)
Kristin Stafford Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2023 4,053 4,053 (0%) 0% 0 Ordinary Shares
Kristin Stafford Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 May 2023 15,873 15,873 - - Stock Option (Right to Buy)
Wilhelmus C. M. Groenhuysen Chief Operating Officer Sale of securities on an exchange or to another person at price $ 76.16 per share. 03 Mar 2023 1,692 230,168 (0%) 0% 76.2 128,862 Ordinary Shares
Wilhelmus C. M. Groenhuysen Chief Operating Officer Sale of securities on an exchange or to another person at price $ 76.16 per share. 03 Mar 2023 3,528 231,860 (0%) 0% 76.2 268,690 Ordinary Shares
Wilhelmus C. M. Groenhuysen Chief Operating Officer Sale of securities on an exchange or to another person at price $ 76.16 per share. 03 Mar 2023 20,415 209,753 (0%) 0% 76.2 1,554,794 Ordinary Shares
Pritesh Shah Chief Growth Officer Sale of securities on an exchange or to another person at price $ 76.16 per share. 03 Mar 2023 1,570 144,650 (0%) 0% 76.2 119,570 Ordinary Shares
Pritesh Shah Chief Growth Officer Sale of securities on an exchange or to another person at price $ 76.16 per share. 03 Mar 2023 16,909 124,799 (0%) 0% 76.2 1,287,779 Ordinary Shares
Pritesh Shah Chief Growth Officer Sale of securities on an exchange or to another person at price $ 76.16 per share. 03 Mar 2023 2,942 141,708 (0%) 0% 76.2 224,061 Ordinary Shares
Uri Weinberg Chief Innovation Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2023 3,936 89,044 (0%) 0% 0 Ordinary Shares
Uri Weinberg Chief Innovation Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2023 28,830 85,108 (0%) 0% 0 Ordinary Shares
Ashley Cordova Chief Financial Officer 03 Mar 2023 4,730 102,085 (0%) 0% 76.2 360,234 Ordinary Shares
Ashley Cordova Chief Financial Officer 03 Mar 2023 775 101,310 (0%) 0% 76.2 59,024 Ordinary Shares
Frank Leonard President, CNS Cancers US Sale of securities on an exchange or to another person at price $ 76.16 per share. 03 Mar 2023 4,403 63,490 (0%) 0% 76.2 335,330 Ordinary Shares
Frank Leonard President, CNS Cancers US Sale of securities on an exchange or to another person at price $ 75.59 per share. 03 Mar 2023 2,315 54,284 (0%) 0% 75.6 174,999 Ordinary Shares
Frank Leonard President, CNS Cancers US Sale of securities on an exchange or to another person at price $ 76.16 per share. 03 Mar 2023 888 62,602 (0%) 0% 76.2 67,630 Ordinary Shares
Frank Leonard President, CNS Cancers US Sale of securities on an exchange or to another person at price $ 75.00 per share. 03 Mar 2023 6,003 56,599 (0%) 0% 75.0 450,206 Ordinary Shares
William Patrick Burke Chief Human Resources Officer Sale of securities on an exchange or to another person at price $ 76.16 per share. 03 Mar 2023 593 66,090 (0%) 0% 76.2 45,163 Ordinary Shares
Wilhelmus C. M. Groenhuysen Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Mar 2023 48,050 231,452 (0%) 0% 0 Ordinary Shares
Wilhelmus C. M. Groenhuysen Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Mar 2023 3,936 235,388 (0%) 0% 0 Ordinary Shares
Wilhelmus C. M. Groenhuysen Chief Operating Officer Sale of securities on an exchange or to another person at price $ 75.28 per share. 02 Mar 2023 1,213 183,402 (0%) 0% 75.3 91,312 Ordinary Shares
Pritesh Shah Chief Growth Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Mar 2023 43,246 146,220 (0%) 0% 0 Ordinary Shares
Pritesh Shah Chief Growth Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Mar 2023 3,936 102,974 (0%) 0% 0 Ordinary Shares
Pritesh Shah Chief Growth Officer Sale of securities on an exchange or to another person at price $ 75.28 per share. 02 Mar 2023 937 99,038 (0%) 0% 75.3 70,535 Ordinary Shares
Ashley Cordova Chief Financial Officer 02 Mar 2023 1,055 95,007 (0%) 0% 75.3 79,418 Ordinary Shares
Ashley Cordova Chief Financial Officer 02 Mar 2023 11,808 106,815 (0%) 0% 0 Ordinary Shares
Frank Leonard President, CNS Cancers US Sale of securities on an exchange or to another person at price $ 75.32 per share. 02 Mar 2023 3,799 59,296 (0%) 0% 75.3 286,154 Ordinary Shares
Frank Leonard President, CNS Cancers US Sale of securities on an exchange or to another person at price $ 77.64 per share. 02 Mar 2023 2,059 67,893 (0%) 0% 77.6 159,859 Ordinary Shares
Frank Leonard President, CNS Cancers US Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Mar 2023 11,808 69,952 (0%) 0% 0 Ordinary Shares
Frank Leonard President, CNS Cancers US Sale of securities on an exchange or to another person at price $ 75.28 per share. 02 Mar 2023 844 58,144 (0%) 0% 75.3 63,535 Ordinary Shares
Frank Leonard President, CNS Cancers US Sale of securities on an exchange or to another person at price $ 76.05 per share. 02 Mar 2023 308 58,988 (0%) 0% 76.1 23,424 Ordinary Shares
William Patrick Burke Chief Human Resources Officer Sale of securities on an exchange or to another person at price $ 75.28 per share. 02 Mar 2023 281 66,683 (0%) 0% 75.3 21,153 Ordinary Shares
Wilhelmus C. M. Groenhuysen Chief Operating Officer Sale of securities on an exchange or to another person at price $ 76.36 per share. 28 Feb 2023 2,164 184,615 (0%) 0% 76.4 165,248 Ordinary Shares
Wilhelmus C. M. Groenhuysen Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2023 21,653 186,779 (0%) 0% 0 Ordinary Shares
Wilhelmus C. M. Groenhuysen Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2023 36,013 36,013 - - Options to Buy Ordinary Shares
Pritesh Shah Chief Growth Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2023 31,691 31,691 - - Options to Buy Ordinary Shares
Pritesh Shah Chief Growth Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2023 19,055 101,898 (0%) 0% 0 Ordinary Shares
Pritesh Shah Chief Growth Officer Sale of securities on an exchange or to another person at price $ 76.36 per share. 28 Feb 2023 1,923 99,975 (0%) 0% 76.4 146,845 Ordinary Shares
Uri Weinberg Chief Innovation Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2023 21,607 21,607 - - Options to Buy Ordinary Shares
Uri Weinberg Chief Innovation Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2023 12,992 56,278 (0%) 0% 0 Ordinary Shares
Ashley Cordova Chief Financial Officer 28 Feb 2023 23,818 98,260 (0%) 0% 0 Ordinary Shares
Ashley Cordova Chief Financial Officer 28 Feb 2023 39,614 39,614 - - Options to Buy Ordinary Shares
Ashley Cordova Chief Financial Officer 28 Feb 2023 2,198 96,062 (0%) 0% 76.4 167,845 Ordinary Shares
Frank Leonard President, CNS Cancers US Sale of securities on an exchange or to another person at price $ 76.36 per share. 28 Feb 2023 1,684 63,095 (0%) 0% 76.4 128,594 Ordinary Shares
Frank Leonard President, CNS Cancers US Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2023 18,621 64,779 (0%) 0% 0 Ordinary Shares
Frank Leonard President, CNS Cancers US Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2023 30,971 30,971 - - Options to Buy Ordinary Shares
William Patrick Burke Chief Human Resources Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2023 12,125 67,719 (0%) 0% 0 Ordinary Shares
William Patrick Burke Chief Human Resources Officer Sale of securities on an exchange or to another person at price $ 76.36 per share. 28 Feb 2023 755 66,964 (0%) 0% 76.4 57,654 Ordinary Shares
William Patrick Burke Chief Human Resources Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2023 20,168 20,168 - - Options to Buy Ordinary Shares
Barak Ben Arye General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2023 17,755 34,907 (0%) 0% 0 Ordinary Shares
Barak Ben Arye General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2023 29,531 29,531 - - Ordinary Shares
Wilhelmus C. M. Groenhuysen Chief Operating Officer Grant, award, or other acquisition of securities at price $ 62.30 per share. 06 Jan 2023 102 165,126 (0%) 0% 62.3 6,355 Ordinary Shares
Ely Benaim Chief Medical Officer Grant, award, or other acquisition of securities at price $ 62.31 per share. 06 Jan 2023 98 28,770 (0%) 0% 62.3 6,106 Ordinary Shares
Ashley Cordova Chief Financial Officer 06 Jan 2023 66 74,442 (0%) 0% 62.3 4,112 Ordinary Shares
William Patrick Burke Chief Human Resources Officer Grant, award, or other acquisition of securities at price $ 62.31 per share. 06 Jan 2023 108 55,594 (0%) 0% 62.3 6,729 Ordinary Shares
Barak Ben Arye General Counsel Grant, award, or other acquisition of securities at price $ 62.31 per share. 06 Jan 2023 150 17,152 (0%) 0% 62.3 9,346 Ordinary Shares
Asaf Danziger Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 119.99 per share. 05 Jan 2023 500 13,583 (0%) 0% 120.0 59,994 Ordinary Shares
Asaf Danziger Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 108.00 per share. 05 Jan 2023 187,500 13,583 (0%) 0% 108 20,250,000 Ordinary Shares
Asaf Danziger Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 62.31 per share. 05 Jan 2023 39 13,622 (0%) 0% 62.3 2,430 Ordinary Shares
Asaf Danziger Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Jan 2023 25,000 0 - - Options to Buy Ordinary Shares
Asaf Danziger Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Jan 2023 187,500 0 - - Options to Buy Ordinary Shares
Asaf Danziger Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.15 per share. 05 Jan 2023 187,500 201,083 (0%) 0% 7.2 1,340,625 Ordinary Shares
Asaf Danziger Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 112.86 per share. 05 Jan 2023 2,000 28,214 (0%) 0% 112.9 225,726 Ordinary Shares
Asaf Danziger Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 111.23 per share. 05 Jan 2023 8,369 30,214 (0%) 0% 111.2 930,916 Ordinary Shares
Asaf Danziger Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 114.35 per share. 05 Jan 2023 4,568 23,646 (0%) 0% 114.4 522,362 Ordinary Shares
Asaf Danziger Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 115.21 per share. 05 Jan 2023 3,702 19,944 (0%) 0% 115.2 426,512 Ordinary Shares
Asaf Danziger Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 116.06 per share. 05 Jan 2023 1,395 18,549 (0%) 0% 116.1 161,906 Ordinary Shares
Asaf Danziger Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 117.01 per share. 05 Jan 2023 999 17,550 (0%) 0% 117.0 116,894 Ordinary Shares
Asaf Danziger Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 118.47 per share. 05 Jan 2023 2,123 15,427 (0%) 0% 118.5 251,515 Ordinary Shares
Asaf Danziger Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.46 per share. 05 Jan 2023 25,000 38,583 (0%) 0% 11.5 286,500 Ordinary Shares
Asaf Danziger Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 119.35 per share. 05 Jan 2023 1,344 14,083 (0%) 0% 119.3 160,405 Ordinary Shares
Pritesh Shah Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 108.00 per share. 05 Jan 2023 387 82,843 (0%) 0% 108 41,796 Ordinary Shares
Uri Weinberg Chief Science Officer Sale of securities on an exchange or to another person at price $ 120.00 per share. 05 Jan 2023 2,379 47,104 (0%) 0% 120 285,480 Ordinary Shares
Uri Weinberg Chief Science Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Jan 2023 1,946 1,946 - - Options to Buy Ordinary Shares
Uri Weinberg Chief Science Officer Sale of securities on an exchange or to another person at price $ 120.00 per share. 05 Jan 2023 1,201 43,286 (0%) 0% 120 144,120 Ordinary Shares
Uri Weinberg Chief Science Officer Sale of securities on an exchange or to another person at price $ 108.00 per share. 05 Jan 2023 2,617 44,487 (0%) 0% 108 282,636 Ordinary Shares
Uri Weinberg Chief Science Officer Sale of securities on an exchange or to another person at price $ 120.00 per share. 05 Jan 2023 1,946 47,104 (0%) 0% 120 233,520 Ordinary Shares
Uri Weinberg Chief Science Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 47.04 per share. 05 Jan 2023 1,946 49,050 (0%) 0% 47.0 91,540 Ordinary Shares
Frank Leonard President, CNS Cancers US Sale of securities on an exchange or to another person at price $ 115.03 per share. 05 Jan 2023 526 47,168 (0%) 0% 115.0 60,508 Ordinary Shares
Frank Leonard President, CNS Cancers US Sale of securities on an exchange or to another person at price $ 108.00 per share. 05 Jan 2023 417 47,694 (0%) 0% 108 45,036 Ordinary Shares
Frank Leonard President, CNS Cancers US Sale of securities on an exchange or to another person at price $ 119.01 per share. 05 Jan 2023 2,345 48,111 (0%) 0% 119.0 279,073 Ordinary Shares
Frank Leonard President, CNS Cancers US Sale of securities on an exchange or to another person at price $ 117.00 per share. 05 Jan 2023 1,010 46,158 (0%) 0% 117 118,170 Ordinary Shares
Frank Leonard President, CNS Cancers US Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.37 per share. 05 Jan 2023 7,826 53,984 (0%) 0% 14.4 112,460 Ordinary Shares
Frank Leonard President, CNS Cancers US Sale of securities on an exchange or to another person at price $ 108.00 per share. 05 Jan 2023 7,826 46,158 (0%) 0% 108 845,208 Ordinary Shares
Frank Leonard President, CNS Cancers US Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.46 per share. 05 Jan 2023 7,500 53,658 (0%) 0% 11.5 85,950 Ordinary Shares
Frank Leonard President, CNS Cancers US Sale of securities on an exchange or to another person at price $ 108.00 per share. 05 Jan 2023 7,500 46,158 (0%) 0% 108 810,000 Ordinary Shares
Frank Leonard President, CNS Cancers US Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.15 per share. 05 Jan 2023 5,517 51,675 (0%) 0% 7.2 39,447 Ordinary Shares
Frank Leonard President, CNS Cancers US Sale of securities on an exchange or to another person at price $ 108.00 per share. 05 Jan 2023 5,517 46,158 (0%) 0% 108 595,836 Ordinary Shares
Frank Leonard President, CNS Cancers US Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.15 per share. 05 Jan 2023 7,183 53,341 (0%) 0% 21.1 151,920 Ordinary Shares
Frank Leonard President, CNS Cancers US Sale of securities on an exchange or to another person at price $ 114.00 per share. 05 Jan 2023 7,183 46,158 (0%) 0% 114.0 818,863 Ordinary Shares
Frank Leonard President, CNS Cancers US Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.15 per share. 05 Jan 2023 7,183 53,341 (0%) 0% 21.1 151,920 Ordinary Shares
Frank Leonard President, CNS Cancers US Sale of securities on an exchange or to another person at price $ 120.00 per share. 05 Jan 2023 7,183 46,158 (0%) 0% 120 861,960 Ordinary Shares
Frank Leonard President, CNS Cancers US Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Jan 2023 7,826 0 - - Options to Buy Ordinary Shares
Frank Leonard President, CNS Cancers US Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Jan 2023 7,500 0 - - Options to Buy Ordinary Shares
Frank Leonard President, CNS Cancers US Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Jan 2023 5,517 0 - - Options to Buy Ordinary Shares
Frank Leonard President, CNS Cancers US Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Jan 2023 7,183 10,479 - - Options to Buy Ordinary Shares
Frank Leonard President, CNS Cancers US Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Jan 2023 7,183 17,662 - - Options to Buy Ordinary Shares
Ashley Cordova Chief Financial Officer 02 Dec 2022 2,000 7,752 - - Options to Buy Ordinary Shares
Ashley Cordova Chief Financial Officer 02 Dec 2022 2,000 74,376 (0%) 0% 7.2 14,300 Ordinary Shares
Frank Leonard President, CNS Cancers US Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Nov 2022 11,609 11,609 - - Options to Buy Ordinary Shares
Frank Leonard President, CNS Cancers US Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Nov 2022 6,830 50,456 (0%) 0% 0 Ordinary Shares
Frank Leonard President, CNS Cancers US Sale of securities on an exchange or to another person at price $ 76.01 per share. 13 Oct 2022 6,754 43,626 (0%) 0% 76.0 513,372 Ordinary Shares
Frank Leonard President, CNS Cancers US Sale of securities on an exchange or to another person at price $ 84.37 per share. 06 Oct 2022 6,754 50,380 (0%) 0% 84.4 569,835 Ordinary Shares
Frank Leonard President, CNS Cancers US Sale of securities on an exchange or to another person at price $ 77.35 per share. 29 Sep 2022 6,754 57,134 (0%) 0% 77.4 522,422 Ordinary Shares
Frank Leonard President, CNS Cancers US Sale of securities on an exchange or to another person at price $ 77.00 per share. 22 Sep 2022 6,754 63,888 (0%) 0% 77 520,058 Ordinary Shares
Frank Leonard Chief Development Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.15 per share. 15 Sep 2022 5,517 82,913 (0%) 0% 7.2 39,447 Ordinary Shares
Frank Leonard Chief Development Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Sep 2022 5,517 5,517 - - Options to Buy Ordinary Shares
Frank Leonard Chief Development Officer Sale of securities on an exchange or to another person at price $ 90.00 per share. 15 Sep 2022 5,517 70,642 (0%) 0% 90 496,530 Ordinary Shares
Frank Leonard Chief Development Officer Sale of securities on an exchange or to another person at price $ 87.31 per share. 15 Sep 2022 6,754 76,159 (0%) 0% 87.3 589,692 Ordinary Shares
Frank Leonard Chief Development Officer Sale of securities on an exchange or to another person at price $ 81.48 per share. 08 Sep 2022 6,754 77,396 (0%) 0% 81.5 550,316 Ordinary Shares
Frank Leonard Chief Development Officer Sale of securities on an exchange or to another person at price $ 78.57 per share. 06 Sep 2022 1,384 86,013 (0%) 0% 78.6 108,741 Ordinary Shares
Wilhelmus C. M. Groenhuysen Chief Operating Officer Sale of securities on an exchange or to another person at price $ 79.04 per share. 02 Sep 2022 296 165,024 (0%) 0% 79.0 23,395 Ordinary Shares
Pritesh Shah Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 79.04 per share. 02 Sep 2022 269 83,230 (0%) 0% 79.0 21,261 Ordinary Shares
Ashley Cordova Chief Financial Officer 02 Sep 2022 885 72,376 (0%) 0% 79.0 69,948 Ordinary Shares
William Patrick Burke Chief Human Resources Officer Sale of securities on an exchange or to another person at price $ 79.04 per share. 02 Sep 2022 718 55,486 (0%) 0% 79.0 56,749 Ordinary Shares
Frank Leonard Chief Development Officer Sale of securities on an exchange or to another person at price $ 77.06 per share. 01 Sep 2022 360 88,467 (0%) 0% 77.1 27,742 Ordinary Shares
Frank Leonard Chief Development Officer Sale of securities on an exchange or to another person at price $ 79.04 per share. 01 Sep 2022 584 87,397 (0%) 0% 79.0 46,158 Ordinary Shares
Frank Leonard Chief Development Officer Sale of securities on an exchange or to another person at price $ 78.96 per share. 01 Sep 2022 48 87,981 (0%) 0% 79.0 3,790 Ordinary Shares
Frank Leonard Chief Development Officer Sale of securities on an exchange or to another person at price $ 78.14 per share. 01 Sep 2022 438 88,029 (0%) 0% 78.1 34,225 Ordinary Shares
Frank Leonard Chief Development Officer Sale of securities on an exchange or to another person at price $ 75.88 per share. 01 Sep 2022 240 88,827 (0%) 0% 75.9 18,210 Ordinary Shares
Frank Leonard Chief Development Officer Sale of securities on an exchange or to another person at price $ 78.68 per share. 01 Sep 2022 1,088 89,067 (0%) 0% 78.7 85,602 Ordinary Shares
Frank Leonard Chief Development Officer Sale of securities on an exchange or to another person at price $ 77.92 per share. 01 Sep 2022 2,720 90,155 (0%) 0% 77.9 211,934 Ordinary Shares
Frank Leonard Chief Development Officer Sale of securities on an exchange or to another person at price $ 76.96 per share. 01 Sep 2022 1,750 92,875 (0%) 0% 77.0 134,677 Ordinary Shares
Frank Leonard Chief Development Officer Sale of securities on an exchange or to another person at price $ 75.93 per share. 01 Sep 2022 1,200 94,625 (0%) 0% 75.9 91,114 Ordinary Shares
Frank Leonard Chief Development Officer Sale of securities on an exchange or to another person at price $ 78.66 per share. 01 Sep 2022 452 95,825 (0%) 0% 78.7 35,556 Ordinary Shares
Frank Leonard Chief Development Officer Sale of securities on an exchange or to another person at price $ 78.08 per share. 01 Sep 2022 2,955 96,277 (0%) 0% 78.1 230,741 Ordinary Shares
Frank Leonard Chief Development Officer Sale of securities on an exchange or to another person at price $ 77.00 per share. 01 Sep 2022 1,914 99,232 (0%) 0% 77.0 147,382 Ordinary Shares
Frank Leonard Chief Development Officer Sale of securities on an exchange or to another person at price $ 75.94 per share. 01 Sep 2022 1,047 101,146 (0%) 0% 75.9 79,504 Ordinary Shares
Ely Benaim Chief Medical Officer Sale of securities on an exchange or to another person at price $ 74.00 per share. 03 Aug 2022 5,396 28,672 (0%) 0% 74 399,304 Ordinary Shares
Ely Benaim Chief Medical Officer Sale of securities on an exchange or to another person at price $ 71.09 per share. 03 Aug 2022 563 34,068 (0%) 0% 71.1 40,024 Ordinary Shares
William F. Doyle Director, Executive Chairman Sale of securities on an exchange or to another person at price $ 69.66 per share. 02 Aug 2022 837 551,176 (0%) 0% 69.7 58,305 Ordinary Shares
Ely Benaim Chief Medical Officer Sale of securities on an exchange or to another person at price $ 69.66 per share. 02 Aug 2022 437 34,631 (0%) 0% 69.7 30,441 Ordinary Shares
Ashley Cordova Chief Financial Officer 02 Aug 2022 7,122 73,261 (0%) 0% 70.2 499,964 Ordinary Shares
Frank Leonard Chief Development Officer Sale of securities on an exchange or to another person at price $ 69.66 per share. 02 Aug 2022 414 102,193 (0%) 0% 69.7 28,839 Ordinary Shares
Wilhelmus C. M. Groenhuysen Chief Operating Officer Grant, award, or other acquisition of securities at price $ 59.07 per share. 05 Jul 2022 218 165,320 (0%) 0% 59.1 12,878 Ordinary Shares
Ely Benaim Chief Medical Officer Grant, award, or other acquisition of securities at price $ 59.08 per share. 05 Jul 2022 222 35,068 (0%) 0% 59.1 13,115 Ordinary Shares
Asaf Danziger Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 59.08 per share. 05 Jul 2022 276 13,583 (0%) 0% 59.1 16,305 Ordinary Shares
Pritesh Shah Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 59.07 per share. 05 Jul 2022 312 83,499 (0%) 0% 59.1 18,431 Ordinary Shares
Uri Weinberg Chief Science Officer Grant, award, or other acquisition of securities at price $ 59.07 per share. 05 Jul 2022 281 49,483 (0%) 0% 59.1 16,600 Ordinary Shares
Ashley Cordova Chief Financial Officer 05 Jul 2022 251 66,139 (0%) 0% 59.1 14,828 Ordinary Shares
Frank Leonard Chief Development Officer Grant, award, or other acquisition of securities at price $ 59.07 per share. 05 Jul 2022 312 102,607 (0%) 0% 59.1 18,431 Ordinary Shares
William Patrick Burke Chief Human Resources Officer Grant, award, or other acquisition of securities at price $ 59.08 per share. 05 Jul 2022 213 56,204 (0%) 0% 59.1 12,583 Ordinary Shares
Barak Ben Arye General Counsel Grant, award, or other acquisition of securities at price $ 59.08 per share. 05 Jul 2022 144 17,002 (0%) 0% 59.1 8,507 Ordinary Shares
Jeryl L. Hilleman Director Sale of securities on an exchange or to another person at price $ 69.61 per share. 10 Jun 2022 407 2,537 (0%) 0% 69.6 28,331 Ordinary Shares
Gabriel Leung Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2022 4,350 4,350 - - Options to Buy Ordinary Shares
Gabriel Leung Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2022 2,427 75,286 - 0 Restricted Stock Units
Timothy John Scannell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2022 8,700 8,700 - - Options to Buy Ordinary Shares
David T. Hung Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2022 4,350 4,350 - - Options to Buy Ordinary Shares
David T. Hung Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2022 2,427 9,141 - 0 Restricted Stock Units
Jeryl L. Hilleman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2022 8,700 8,700 - - Options to Buy Ordinary Shares
W. Anthony Vernon Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2022 8,700 8,700 - - Options to Buy Ordinary Shares
Martin J. Madden Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2022 8,700 8,700 - - Options to Buy Ordinary Shares
Ely Benaim Chief Medical Officer Sale of securities on an exchange or to another person at price $ 65.16 per share. 10 May 2022 2,070 36,981 (0%) 0% 65.2 134,877 Ordinary Shares
Ely Benaim Chief Medical Officer Sale of securities on an exchange or to another person at price $ 61.25 per share. 10 May 2022 2,135 34,846 (0%) 0% 61.3 130,769 Ordinary Shares
Wilhelmus C. M. Groenhuysen Chief Operating Officer Gift of securities by or to the insider at price $ 0.00 per share. 05 May 2022 1,324 147,048 - - Options to Buy Ordinary Shares
Wilhelmus C. M. Groenhuysen Chief Operating Officer Gift of securities by or to the insider at price $ 0.00 per share. 05 May 2022 1,324 0 - - Options to Buy Ordinary Shares
William F. Doyle Director, Executive Chairman Sale of securities on an exchange or to another person at price $ 70.10 per share. 08 Mar 2022 2,385 552,013 (0%) 0% 70.1 167,189 Ordinary Shares
Wilhelmus C. M. Groenhuysen Chief Operating Officer Sale of securities on an exchange or to another person at price $ 70.10 per share. 08 Mar 2022 2,923 165,102 (0%) 0% 70.1 204,902 Ordinary Shares
Todd Christopher Longsworth General Counsel Sale of securities on an exchange or to another person at price $ 70.10 per share. 08 Mar 2022 2,339 62,462 (0%) 0% 70.1 163,964 Ordinary Shares
Ashley Cordova Chief Financial Officer 08 Mar 2022 759 60,848 (0%) 0% 70.1 53,206 Ordinary Shares
Frank Leonard Chief Development Officer Sale of securities on an exchange or to another person at price $ 70.10 per share. 08 Mar 2022 744 102,295 (0%) 0% 70.1 52,154 Ordinary Shares
William Patrick Burke Chief Human Resources Officer Sale of securities on an exchange or to another person at price $ 70.10 per share. 08 Mar 2022 1,037 55,991 (0%) 0% 70.1 72,694 Ordinary Shares
Pritesh Shah Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 70.10 per share. 07 Mar 2022 2,481 81,908 (0%) 0% 70.1 173,918 Ordinary Shares
Pritesh Shah Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 69.55 per share. 07 Mar 2022 5,294 84,389 (0%) 0% 69.6 368,198 Ordinary Shares
William F. Doyle Director, Executive Chairman Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2022 14,581 14,581 - - Options to Buy Ordinary Shares
Wilhelmus C. M. Groenhuysen Chief Operating Officer Sale of securities on an exchange or to another person at price $ 74.50 per share. 03 Mar 2022 1,301 170,594 (0%) 0% 74.5 96,922 Ordinary Shares
Wilhelmus C. M. Groenhuysen Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2022 7,664 7,664 - - Options to Buy Ordinary Shares
Wilhelmus C. M. Groenhuysen Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2022 38,390 38,390 - - Options to Buy Ordinary Shares
Wilhelmus C. M. Groenhuysen Chief Operating Officer Sale of securities on an exchange or to another person at price $ 70.41 per share. 03 Mar 2022 2,569 168,025 (0%) 0% 70.4 180,876 Ordinary Shares
Wilhelmus C. M. Groenhuysen Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2022 21,921 171,895 (0%) 0% 0 Ordinary Shares
Ely Benaim Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2022 5,452 5,452 - - Options to Buy Ordinary Shares
Ely Benaim Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2022 17,371 45,570 (0%) 0% 0 Ordinary Shares
Ely Benaim Chief Medical Officer Sale of securities on an exchange or to another person at price $ 74.50 per share. 03 Mar 2022 803 44,767 (0%) 0% 74.5 59,822 Ordinary Shares
Ely Benaim Chief Medical Officer Sale of securities on an exchange or to another person at price $ 70.41 per share. 03 Mar 2022 1,510 43,257 (0%) 0% 70.4 106,315 Ordinary Shares
Ely Benaim Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2022 30,422 30,422 - - Options to Buy Ordinary Shares
Asaf Danziger Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2022 13,470 13,470 - - Options to Buy Ordinary Shares
Todd Christopher Longsworth General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2022 6,106 6,106 - - Options to Buy Ordinary Shares
Todd Christopher Longsworth General Counsel Sale of securities on an exchange or to another person at price $ 70.41 per share. 03 Mar 2022 1,973 64,801 (0%) 0% 70.4 138,913 Ordinary Shares
Todd Christopher Longsworth General Counsel Sale of securities on an exchange or to another person at price $ 74.50 per share. 03 Mar 2022 1,094 66,774 (0%) 0% 74.5 81,501 Ordinary Shares
Pritesh Shah Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 73.34 per share. 03 Mar 2022 2,632 91,597 (0%) 0% 73.3 193,031 Ordinary Shares
Pritesh Shah Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 74.50 per share. 03 Mar 2022 997 94,229 (0%) 0% 74.5 74,275 Ordinary Shares
Pritesh Shah Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2022 6,231 6,231 - - Options to Buy Ordinary Shares
Pritesh Shah Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2022 38,027 38,027 - - Options to Buy Ordinary Shares
Pritesh Shah Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 70.41 per share. 03 Mar 2022 1,914 89,683 (0%) 0% 70.4 134,759 Ordinary Shares
Pritesh Shah Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2022 21,714 95,226 (0%) 0% 0 Ordinary Shares
Uri Weinberg Chief Science Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2022 30,422 30,422 - - Options to Buy Ordinary Shares
Uri Weinberg Chief Science Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2022 4,961 4,961 - - Options to Buy Ordinary Shares
Uri Weinberg Chief Science Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2022 17,371 49,186 (0%) 0% 0 Ordinary Shares
Ashley Cordova Chief Financial Officer 03 Mar 2022 1,200 7,736 - - Options to Buy Ordinary Shares
Ashley Cordova Chief Financial Officer 03 Mar 2022 5,140 5,140 - - Options to Buy Ordinary Shares
Ashley Cordova Chief Financial Officer 03 Mar 2022 37,664 37,664 - - Options to Buy Ordinary Shares
Ashley Cordova Chief Financial Officer 03 Mar 2022 556 61,607 (0%) 0% 70.4 39,146 Ordinary Shares
Ashley Cordova Chief Financial Officer 03 Mar 2022 1,149 62,163 (0%) 0% 74.5 85,598 Ordinary Shares
Ashley Cordova Chief Financial Officer 03 Mar 2022 21,508 63,312 (0%) 0% 0 Ordinary Shares
Ashley Cordova Chief Financial Officer 03 Mar 2022 3,840 64,688 (0%) 0% 15.6 59,904 Ordinary Shares
Ashley Cordova Chief Financial Officer 03 Mar 2022 1,200 65,888 (0%) 0% 11.5 13,752 Ordinary Shares
Ashley Cordova Chief Financial Officer 03 Mar 2022 3,840 0 - - Options to Buy Ordinary Shares
Frank Leonard Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2022 30,422 30,422 - - Options to Buy Ordinary Shares
Frank Leonard Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2022 4,933 4,933 - - Options to Buy Ordinary Shares
Frank Leonard Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2022 17,371 104,524 (0%) 0% 0 Ordinary Shares
Frank Leonard Chief Development Officer Sale of securities on an exchange or to another person at price $ 74.50 per share. 03 Mar 2022 930 103,594 (0%) 0% 74.5 69,283 Ordinary Shares
Frank Leonard Chief Development Officer Sale of securities on an exchange or to another person at price $ 70.41 per share. 03 Mar 2022 555 103,039 (0%) 0% 70.4 39,076 Ordinary Shares
William Patrick Burke Chief Human Resources Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2022 7,445 58,395 (0%) 0% 0 Ordinary Shares
William Patrick Burke Chief Human Resources Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2022 4,361 4,361 - - Options to Buy Ordinary Shares
William Patrick Burke Chief Human Resources Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2022 13,038 13,038 - - Options to Buy Ordinary Shares
William Patrick Burke Chief Human Resources Officer Sale of securities on an exchange or to another person at price $ 70.41 per share. 03 Mar 2022 1,026 57,028 (0%) 0% 70.4 72,238 Ordinary Shares
William Patrick Burke Chief Human Resources Officer Sale of securities on an exchange or to another person at price $ 74.50 per share. 03 Mar 2022 341 58,054 (0%) 0% 74.5 25,404 Ordinary Shares
Wilhelmus C. M. Groenhuysen Chief Operating Officer Grant, award, or other acquisition of securities at price $ 63.81 per share. 06 Jan 2022 75 149,974 (0%) 0% 63.8 4,786 Ordinary Shares
Ely Benaim Chief Medical Officer Grant, award, or other acquisition of securities at price $ 63.82 per share. 06 Jan 2022 55 28,199 (0%) 0% 63.8 3,510 Ordinary Shares
Asaf Danziger Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 63.81 per share. 06 Jan 2022 31 13,307 (0%) 0% 63.8 1,978 Ordinary Shares
Uri Weinberg Chief Science Officer Grant, award, or other acquisition of securities at price $ 63.83 per share. 06 Jan 2022 35 31,815 (0%) 0% 63.8 2,234 Ordinary Shares
Ashley Cordova Chief Financial Officer 06 Jan 2022 46 41,804 (0%) 0% 63.8 2,936 Ordinary Shares
William Patrick Burke Chief Human Resources Officer Grant, award, or other acquisition of securities at price $ 63.81 per share. 06 Jan 2022 80 50,950 (0%) 0% 63.8 5,105 Ordinary Shares
William Patrick Burke Chief Human Resources Officer Sale of securities on an exchange or to another person at price $ 75.96 per share. 03 Jan 2022 2,633 41,036 (0%) 0% 76.0 200,003 Ordinary Shares
William Patrick Burke Chief Human Resources Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.15 per share. 03 Jan 2022 9,750 50,786 (0%) 0% 7.2 69,713 Ordinary Shares
William Patrick Burke Chief Human Resources Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.60 per share. 03 Jan 2022 1,402 51,269 (0%) 0% 21.6 30,283 Ordinary Shares
William Patrick Burke Chief Human Resources Officer Sale of securities on an exchange or to another person at price $ 76.09 per share. 03 Jan 2022 919 49,867 (0%) 0% 76.1 69,924 Ordinary Shares
William Patrick Burke Chief Human Resources Officer Sale of securities on an exchange or to another person at price $ 76.03 per share. 03 Jan 2022 399 50,870 (0%) 0% 76.0 30,336 Ordinary Shares
William Patrick Burke Chief Human Resources Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Jan 2022 17,452 0 - - Options to Buy Ordinary Shares
William Patrick Burke Chief Human Resources Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Jan 2022 1,402 6,098 - - Options to Buy Ordinary Shares
William Patrick Burke Chief Human Resources Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Jan 2022 9,750 0 - - Options to Buy Ordinary Shares
William Patrick Burke Chief Human Resources Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.46 per share. 03 Jan 2022 17,452 43,669 (0%) 0% 11.5 200,000 Ordinary Shares
Asaf Danziger Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 103.37 per share. 26 Nov 2021 1,000 13,172 (0%) 0% 103.4 103,370 Ordinary Shares
Asaf Danziger Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 96.50 per share. 26 Nov 2021 104 13,276 (0%) 0% 96.5 10,036 Ordinary Shares
Asaf Danziger Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 102.36 per share. 26 Nov 2021 3,870 12,172 (0%) 0% 102.4 396,133 Ordinary Shares
Ashley Cordova Chief Financial Officer 02 Nov 2021 209 41,758 (0%) 0% 107.3 22,421 Ordinary Shares
Wilhelmus C. M. Groenhuysen Chief Operating Officer Sale of securities on an exchange or to another person at price $ 138.23 per share. 02 Sep 2021 181 149,899 (0%) 0% 138.2 25,020 Ordinary Shares
Pritesh Shah Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 139.24 per share. 02 Sep 2021 150 73,542 (0%) 0% 139.2 20,886 Ordinary Shares
Pritesh Shah Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 140.17 per share. 02 Sep 2021 30 73,512 (0%) 0% 140.2 4,205 Ordinary Shares
Pritesh Shah Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 138.27 per share. 02 Sep 2021 321 73,692 (0%) 0% 138.3 44,386 Ordinary Shares
Pritesh Shah Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 138.23 per share. 02 Sep 2021 156 74,013 (0%) 0% 138.2 21,564 Ordinary Shares
Ashley Cordova Chief Financial Officer 02 Sep 2021 828 41,967 (0%) 0% 138.2 114,456 Ordinary Shares
Frank Leonard Chief Development Officer Sale of securities on an exchange or to another person at price $ 138.23 per share. 02 Sep 2021 540 87,153 (0%) 0% 138.2 74,645 Ordinary Shares
Ashley Cordova Chief Financial Officer 12 Aug 2021 8,026 54,019 (0%) 0% 21.5 172,559 Ordinary Shares
Ashley Cordova Chief Financial Officer 12 Aug 2021 2,606 6,375 - - Options to Buy Ordinary Shares
Ashley Cordova Chief Financial Officer 12 Aug 2021 7,298 5,172 - - Options to Buy Ordinary Shares
Ashley Cordova Chief Financial Officer 12 Aug 2021 2,767 5,533 - - Options to Buy Ordinary Shares
Ashley Cordova Chief Financial Officer 12 Aug 2021 8,026 3,297 - - Options to Buy Ordinary Shares
Ashley Cordova Chief Financial Officer 12 Aug 2021 5,927 0 - - Options to Buy Ordinary Shares
Ashley Cordova Chief Financial Officer 12 Aug 2021 10,000 3,840 - - Options to Buy Ordinary Shares
Ashley Cordova Chief Financial Officer 12 Aug 2021 1,733 44,260 (0%) 0% 0 Ordinary Shares
Ashley Cordova Chief Financial Officer 12 Aug 2021 2,606 45,993 (0%) 0% 140.9 367,185 Ordinary Shares
Ashley Cordova Chief Financial Officer 12 Aug 2021 2,606 48,599 (0%) 0% 69.4 180,778 Ordinary Shares
Ashley Cordova Chief Financial Officer 12 Aug 2021 7,298 45,993 (0%) 0% 140.9 1,028,288 Ordinary Shares
Ashley Cordova Chief Financial Officer 12 Aug 2021 7,298 53,291 (0%) 0% 47.0 343,298 Ordinary Shares
Ashley Cordova Chief Financial Officer 12 Aug 2021 2,767 45,993 (0%) 0% 140.9 389,870 Ordinary Shares
Ashley Cordova Chief Financial Officer 12 Aug 2021 2,767 48,760 (0%) 0% 32.0 88,599 Ordinary Shares
Ashley Cordova Chief Financial Officer 12 Aug 2021 8,026 45,993 (0%) 0% 140.9 1,130,879 Ordinary Shares
Ashley Cordova Chief Financial Officer 12 Aug 2021 5,927 45,993 (0%) 0% 141.1 836,063 Ordinary Shares
Ashley Cordova Chief Financial Officer 12 Aug 2021 5,927 51,920 (0%) 0% 19.3 114,095 Ordinary Shares
Ashley Cordova Chief Financial Officer 12 Aug 2021 10,000 45,993 (0%) 0% 15.6 156,000 Ordinary Shares
Wilhelmus C. M. Groenhuysen Chief Operating Officer Gift of securities by or to the insider at price $ 0.00 per share. 10 Aug 2021 320 145,724 - - Options to Buy Ordinary Shares
Wilhelmus C. M. Groenhuysen Chief Operating Officer Gift of securities by or to the insider at price $ 0.00 per share. 10 Aug 2021 320 1,324 - - Options to Buy Ordinary Shares
Gabriel Leung Director Sale of securities on an exchange or to another person at price $ 152.50 per share. 05 Aug 2021 1,000 72,859 (0%) 0% 152.5 152,500 Ordinary Shares
Gabriel Leung Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Aug 2021 1,000 2,345 - - Options to Buy Ordinary Shares
Gabriel Leung Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 31.45 per share. 05 Aug 2021 1,000 73,859 (0%) 0% 31.5 31,450 Ordinary Shares
Martin J. Madden Director Sale of securities on an exchange or to another person at price $ 153.12 per share. 05 Aug 2021 34 384 (0%) 0% 153.1 5,206 Ordinary Shares
Pritesh Shah Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 148.71 per share. 04 Aug 2021 2,063 74,169 (0%) 0% 148.7 306,789 Ordinary Shares
Ely Benaim Chief Medical Officer Sale of securities on an exchange or to another person at price $ 150.11 per share. 03 Aug 2021 464 28,144 (0%) 0% 150.1 69,651 Ordinary Shares
Pritesh Shah Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 149.43 per share. 03 Aug 2021 1,654 76,232 (0%) 0% 149.4 247,157 Ordinary Shares
William F. Doyle Director, Executive Chairman Sale of securities on an exchange or to another person at price $ 149.38 per share. 02 Aug 2021 995 554,398 (0%) 0% 149.4 148,631 Ordinary Shares
Frank Leonard Chief Development Officer Sale of securities on an exchange or to another person at price $ 149.38 per share. 02 Aug 2021 713 89,486 (0%) 0% 149.4 106,507 Ordinary Shares
Frank Leonard Chief Development Officer Sale of securities on an exchange or to another person at price $ 149.43 per share. 02 Aug 2021 328 89,158 (0%) 0% 149.4 49,013 Ordinary Shares
Ely Benaim Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 83.30 per share. 30 Jul 2021 651 29,795 (0%) 0% 83.3 54,228 Ordinary Shares
Ely Benaim Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Jul 2021 651 3,253 - - Options to Buy Ordinary Shares
Ely Benaim Chief Medical Officer Sale of securities on an exchange or to another person at price $ 149.38 per share. 30 Jul 2021 536 28,608 (0%) 0% 149.4 80,067 Ordinary Shares
Ely Benaim Chief Medical Officer Sale of securities on an exchange or to another person at price $ 158.96 per share. 30 Jul 2021 651 29,144 (0%) 0% 159.0 103,483 Ordinary Shares
Gabriel Leung Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Jul 2021 1,000 3,345 - - Options to Buy Ordinary Shares
Gabriel Leung Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 31.45 per share. 06 Jul 2021 1,000 73,859 (0%) 0% 31.5 31,450 Ordinary Shares
Gabriel Leung Director Sale of securities on an exchange or to another person at price $ 183.54 per share. 06 Jul 2021 1,000 72,859 (0%) 0% 183.5 183,540 Ordinary Shares
Wilhelmus C. M. Groenhuysen Chief Operating Officer Grant, award, or other acquisition of securities at price $ 137.12 per share. 06 Jul 2021 66 150,080 (0%) 0% 137.1 9,050 Ordinary Shares
Ely Benaim Chief Medical Officer Grant, award, or other acquisition of securities at price $ 137.12 per share. 06 Jul 2021 90 29,144 (0%) 0% 137.1 12,341 Ordinary Shares
Asaf Danziger Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 137.12 per share. 06 Jul 2021 118 8,302 (0%) 0% 137.1 16,180 Ordinary Shares
Todd Christopher Longsworth General Counsel Grant, award, or other acquisition of securities at price $ 137.12 per share. 06 Jul 2021 154 67,868 (0%) 0% 137.1 21,117 Ordinary Shares
Pritesh Shah Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 137.12 per share. 06 Jul 2021 154 77,886 - 137.1 21,117 Restricted Share Units
Uri Weinberg Chief Science Officer Grant, award, or other acquisition of securities at price $ 137.12 per share. 06 Jul 2021 113 31,780 (0%) 0% 137.1 15,495 Ordinary Shares
Ashley Cordova Chief Financial Officer 06 Jul 2021 100 35,993 (0%) 0% 137.1 13,712 Ordinary Shares
Frank Leonard Chief Development Officer Grant, award, or other acquisition of securities at price $ 137.12 per share. 06 Jul 2021 154 90,199 (0%) 0% 137.1 21,117 Ordinary Shares
Pritesh Shah Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 215.00 per share. 10 Jun 2021 23,540 77,732 (0%) 0% 215 5,061,100 Ordinary Shares
Gabriel Leung Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2021 814 72,859 - 0 Restricted Stock Units
Gabriel Leung Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2021 1,499 1,499 - - Options to Buy Ordinary Shares
Sherilyn S. McCoy Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2021 814 6,714 - 0 Restricted Stock Units
Sherilyn S. McCoy Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2021 1,499 1,499 - - Options to Buy Ordinary Shares
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters